tiprankstipranks
ImmunityBio (IBRX)
NASDAQ:IBRX
US Market
IBRX
ImmunityBio
RESEARCH TOOLSreports

ImmunityBio (IBRX) Stock News & Sentiment

2,386 Followers
ImmunityBio Addresses FDA Warning on ANKTIVA Promotion
Premium
Company Announcements
ImmunityBio Addresses FDA Warning on ANKTIVA Promotion
7d ago
8K
IBRX
ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up
Premium
Weekend Updates
ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up
9d ago
AFL
MCO
ImmunityBio Bolsters Balance Sheet With New Financing Moves
Premium
Company Announcements
ImmunityBio Bolsters Balance Sheet With New Financing Moves
13d ago
8K
IBRX
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Soon-Shiong Allegedly Overstated ANKTIVA Efficacy: Levi & Korsinsky
Premium
Class Action
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Soon-Shiong Allegedly Overstated ANKTIVA Efficacy: Levi & Korsinsky
14d ago
IBRX
ImmunityBio Faces Securities Lawsuit Over Alleged Misleading Statements About Cancer Drug Anktiva
Premium
Class Action
ImmunityBio Faces Securities Lawsuit Over Alleged Misleading Statements About Cancer Drug Anktiva
14d ago
IBRX
“FDA Warning” on Cancer Drug Sends ImmunityBio Stock (IBRX) Tumbling over 26%
Premium
Market News
“FDA Warning” on Cancer Drug Sends ImmunityBio Stock (IBRX) Tumbling over 26%
20d ago
IBRX
Buy Rating on ANKTIVA: NCCN Guideline Expansion, Off‑Label Upside, and DCF‑Backed Risk‑Reward in BCG‑Unresponsive NMIBC
Premium
Ratings
Buy Rating on ANKTIVA: NCCN Guideline Expansion, Off‑Label Upside, and DCF‑Backed Risk‑Reward in BCG‑Unresponsive NMIBC
26d ago
IBRX
More IBRX News >

IBRX News on the Web

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
Zacks
Bullish
Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and ImmunityBio (IBRX)
TipRanks News
Neutral
ImmunityBio Stock Jumps on Expanding Cancer Drug Reach
TipRanks News
Bullish
ImmunityBio (IBRX) Surpasses Q1 Revenue Expectations with Strong Growth
GuruFocus News
Neutral
ImmunityBio reports preliminary Q1 net product revenue $44.2M
TipRanks News
Bullish
ImmunityBio Stock Sinks as FDA, Lawsuits Spook Wall Street
TipRanks News
Bearish
IBRX Responds to FDA Warning Over Misleading Cancer Drug Claims
Zacks
Bearish
Why ImmunityBio Stock Slumped on Monday
The Motley Fool
Bearish

News Score - Last 7 Days

Neutral
IBRX
Sector Average
Media Buzz
This Week7 articles
Weekly Average13.25 articles
News Sentiment
This Week60%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IBRX’s Media Buzz Sentiment?
7 articles about IBRX were published this week. In an average week, 13.25 articles are published.
    What is IBRX’s weekly average amount of articles?
    In an average week, 13.25 articles about IBRX are published.
      What is IBRX’s News Sentiment?
      60% of articles about IBRX were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        STAAStaar Surgical
        IVVDInvivyd
        SLPSimulations Plus
        REPLReplimune Group
        Showing the stocks with the most bullish news sentiment over the past week